Cryolife names VP-regulatory affairs & quality control
This article was originally published in The Gray Sheet
Executive Summary
Thomas Lynch, PhD, replaces Jim VanderWyk, re-assigned to VP-product integrity. Lynch previously served stints as Clearant's senior VP-regulatory affairs & quality assurance, and as FDA division of hematology deputy director. The management changes follow 23 product liability cases due to patients receiving contaminated tissue (1"The Gray Sheet" July 21, 2003, In Brief)...